(19)
(11) EP 4 031 230 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.01.2025 Bulletin 2025/02

(45) Mention of the grant of the patent:
04.12.2024 Bulletin 2024/49

(21) Application number: 20780724.9

(22) Date of filing: 01.10.2020
(51) International Patent Classification (IPC): 
A61M 39/02(2006.01)
 A61M 39/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 39/0208; A61M 39/28; A61M 39/281
(86) International application number:
PCT/EP2020/077511
(87) International publication number:
WO 2021/078488 (29.04.2021 Gazette 2021/17)

(54)

IMPLANTABLE ACCESS DEVICE FOR ACCESSING THE VASCULAR SYSTEM OF A HUMAN OR ANIMAL BODY, PARTICULARLY SUBCUTANEOUSLY IMPLANTABLE ACCESS PORT

IMPLANTIERBARE ZUGANGSVORRICHTUNG ZUM ZUGRIFF AUF DAS GEFÄSSSYSTEM EINES MENSCHLICHEN ODER TIERISCHEN KÖRPERS, INSBESONDERE EIN SUBKUTAN IMPLANTIERBARER ZUGANGSANSCHLUSS

DISPOSITIF D'ACCÈS IMPLANTABLE POUR ACCÉDER AU SYSTÈME VASCULAIRE D'UN CORPS HUMAIN OU ANIMAL, EN PARTICULIER ORIFICE D'ACCÈS IMPLANTABLE EN SOUS-CUTANÉ

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.10.2019 IT 201900019761

(43) Date of publication of application:
27.07.2022 Bulletin 2022/30

(73) Proprietor: pfm medical gmbh
50996 Köln (DE)

(72) Inventors:
  • ACHARD DE LA VENTE, Stanislas Marie
    2300 La Chaux de Fonds (CH)
  • BERGEON, Cyril
    25130 Villers le lac (FR)

(74) Representative: Lippert Stachow Patentanwälte Rechtsanwälte Part.mbB 
Hohenzollernring 79-83 (Capitol)
50672 Köln
50672 Köln (DE)


(56) References cited: : 
EP-A1- 1 245 247
WO-A1-01/32141
 EP-A1- 3 381 501
WO-A2-2012/064881
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).